Episodes
-
What is science?
-
Karmma 3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor
-
Missing episodes?
-
I get into endpoints, surrogates, validation, blinding, crossover, and control arms.
-
I talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more. Then Papa Heme Tells you How to Find your First Job
-
Dr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time.
-
Mike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more.
-
A new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer
-
I destroy the trial. Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can.
-
I annotate an online case discussion; Every decision is not based in evidence. Madness
-
This lecture on Burnout will not be like any other you have heard
-
I break down the GEM CESAR trial
K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer
What a crazy trial! -
This uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative. Sad day for oncology
-
Sample size games, primary endpoint, head to head trials in oncology
Rate this podcast on itunes
Coming next is Triangle trial -
Grand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed)
More ASH coming soon -
Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
-
In this lecture given December 7, 2022, I cover 5 things:
Vaccines
Masking
Long COVID
Schools/Immunity Debt
Paxlovid -
Should we treat smoldering MM, a debate
Long COVID vs Long URI
Review the show; Say Hi at ASH22 -
Smart Start is a useless lymphoma study; We have to stop putting our careers ahead of patients. In the second part, I discuss the 'experts' featured on STAT. Wowzers.
I will be at ask. Hit me up:
[email protected] -
I am joined by Cornell Professor Paul Fenyves; a practicing internist Dr. Fenyves walks us through COVID19 policy. We will be back soon with more cancer medicine. Including a devastating lymphoma one.
-
I was invited to give this talk to a UK conference on Myeloma
Please LEAVE A REVIEW of this podcast - Show more
